Immunotherapy in lymphoma

Saved in:
Bibliographic Details
Published inHematological oncology Vol. 35; no. S1; pp. 88 - 91
Main Authors Ansell, Stephen M., Caligaris‐Cappio, Federico, Maloney, David G.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.06.2017
Subjects
Immunotherapy
Lymphoma
Online AccessGet full text
ISSN0278-0232
1099-1069
1099-1069
DOI10.1002/hon.2408

Cover

Author Maloney, David G.
Ansell, Stephen M.
Caligaris‐Cappio, Federico
Author_xml – sequence: 1
  givenname: Stephen M.
  surname: Ansell
  fullname: Ansell, Stephen M.
  email: ansell.stephen@mayo.edu
  organization: Mayo Clinic
– sequence: 2
  givenname: Federico
  surname: Caligaris‐Cappio
  fullname: Caligaris‐Cappio, Federico
  organization: Italian Association for Cancer Research (AIRC)
– sequence: 3
  givenname: David G.
  surname: Maloney
  fullname: Maloney, David G.
  organization: Fred Hutchinson Cancer Research Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28591421$$D View this record in MEDLINE/PubMed
BookMark eNp10M9LwzAUB_AgE_dDwasXGXjx0vmStE1ylKFuMNxFzyGtCetom5q0SP97M7cpiIZAHuSTx8t3jAa1rTVClxhmGIDcbWw9IzHwEzTCIESEIRUDNALCeASEkiEae78FCHfAz9CQ8ETgmOARulpWVVfbdqOdavppUU_Lvmo2tlLn6NSo0uuLwzlBr48PL_NFtFo_Lef3qyinnPKIGKFp2DpLuVEZUxlRAGlOMY5jo3SSK2BgkoSnlLLU5IxmwlCCBQtVntAJut33bZx977RvZVX4XJelqrXtvMQCGCUxDWuCbn7Rre1cHabbqTQlJMYsqOuD6rJKv8nGFZVyvTx-OoDZHuTOeu-0kXnRqrawdetUUUoMcpeqDKnKXao_I34_OPb8g0Z7-lGUuv_XycX6-ct_Aszxgjc
CitedBy_id crossref_primary_10_25259_SNI_584_2022
crossref_primary_10_1111_jvim_15898
crossref_primary_10_3390_molecules27103354
crossref_primary_10_3390_diagnostics11101875
crossref_primary_10_1016_j_annder_2019_04_021
crossref_primary_10_3233_XST_200642
Cites_doi 10.1016/j.celrep.2016.01.042
10.1200/JCO.2014.56.2025
10.1056/NEJMoa1411087
10.1158/1078-0432.CCR-09-1339
10.1016/j.ccr.2011.11.006
10.1126/scitranslmed.aaf8621
10.1200/JCO.2012.48.3685
10.1016/S1470-2045(16)30167-X
10.1182/blood.V128.22.4192.4192
10.1200/JCO.2016.67.3467
10.1200/JCO.2015.65.9789
10.1182/blood.V128.22.998.998
10.1172/JCI63186
10.1182/blood-2014-05-552729
ContentType Journal Article
Copyright Copyright © 2017 John Wiley & Sons, Ltd.
Copyright_xml – notice: Copyright © 2017 John Wiley & Sons, Ltd.
DBID AAYXX
CITATION
NPM
7QL
7QO
7QP
7T7
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
DOI 10.1002/hon.2408
DatabaseName CrossRef
PubMed
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Virology and AIDS Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Genetics Abstracts
Biotechnology Research Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1099-1069
EndPage 91
ExternalDocumentID 28591421
10_1002_hon_2408
HON2408
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GLUZI
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
TEORI
UB1
UDS
V2E
V8K
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XV2
ZGI
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7QL
7QO
7QP
7T7
7TK
7U9
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
ID FETCH-LOGICAL-c3838-2f9e39e3eb68fab7ab2a006c31144fae5ca070f55863376fc73b9f3219773bc53
IEDL.DBID DR2
ISSN 0278-0232
1099-1069
IngestDate Fri Jul 11 12:26:46 EDT 2025
Sat Jul 26 02:19:51 EDT 2025
Wed Feb 19 02:41:59 EST 2025
Tue Jul 01 01:30:17 EDT 2025
Thu Apr 24 23:08:16 EDT 2025
Wed Jan 22 16:39:51 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue S1
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3838-2f9e39e3eb68fab7ab2a006c31144fae5ca070f55863376fc73b9f3219773bc53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.2408
PMID 28591421
PQID 1906622417
PQPubID 2034140
PageCount 4
ParticipantIDs proquest_miscellaneous_1907324333
proquest_journals_1906622417
pubmed_primary_28591421
crossref_citationtrail_10_1002_hon_2408
crossref_primary_10_1002_hon_2408
wiley_primary_10_1002_hon_2408_HON2408
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2017
2017-06-00
2017-Jun
20170601
PublicationDateYYYYMMDD 2017-06-01
PublicationDate_xml – month: 06
  year: 2017
  text: June 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
PublicationTitle Hematological oncology
PublicationTitleAlternate Hematol Oncol
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2011; 20
2015; 372
2008; 118
2012; 122
2016; 17
2016; 14
2016; 8
2009; 15
2013; 31
2016; 34
2015; 33
2014; 124
e_1_2_6_10_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_7_1
Ramsay AG (e_1_2_6_4_1) 2008; 118
e_1_2_6_6_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_2_1
e_1_2_6_12_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – volume: 124
  start-page: 188
  issue: 2
  year: 2014
  end-page: 95
  article-title: Current concepts in the diagnosis and management of cytokine release syndrome
  publication-title: Blood
– volume: 31
  start-page: 4199
  issue: 33
  year: 2013
  end-page: 206
  article-title: Disabling immune tolerance by programmed death‐1 blockade with pidilizumab after autologous hematopoietic stem‐cell transplantation for diffuse large B‐cell lymphoma: results of an international phase II trial
  publication-title: J Clin Oncol
– volume: 34
  start-page: 2698
  issue: 23
  year: 2016
  end-page: 704
  article-title: Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study
  publication-title: J Clin Oncol
– volume: 20
  start-page: 728
  issue: 6
  year: 2011
  end-page: 40
  article-title: Combined genetic inactivation of β2‐Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma
  publication-title: Cancer Cell
– volume: 34
  start-page: 3733
  year: 2016
  end-page: 3739
  article-title: Programmed death‐1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure
  publication-title: J Clin Oncol
– volume: 372
  start-page: 311
  issue: 4
  year: 2015
  end-page: 319
  article-title: PD‐1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
  publication-title: N Engl J Med
– volume: 122
  start-page: 3424
  issue: 10
  year: 2012
  end-page: 31
  article-title: Pathogenesis of follicular lymphoma
  publication-title: J Clin Invest
– volume: 17
  start-page: 1283
  issue: 9
  year: 2016
  end-page: 94
  article-title: Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem‐cell transplantation and brentuximab vedotin: a multicentre, multicohort, single‐arm phase 2 trial
  publication-title: Lancet Oncol
– volume: 14
  start-page: 1748
  issue: 7
  year: 2016
  end-page: 60
  article-title: Targeting macrophages sensitizes chronic lymphocytic leukemia to apoptosis and inhibits disease progression
  publication-title: Cell Rep
– volume: 15
  start-page: 6446
  issue: 20
  year: 2009
  end-page: 53
  article-title: Phase I study of ipilimumab, an anti‐CTLA‐4 monoclonal antibody, in patients with relapsed and refractory B‐cell non‐Hodgkin lymphoma
  publication-title: Clin Cancer Res
– volume: 8
  issue: 355
  year: 2016
  article-title: Immunotherapy of non‐Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19‐specific chimeric antigen receptor‐modified T cells
  publication-title: Sci Transl Med
– volume: 118
  start-page: 2427
  issue: 7
  year: 2008
  end-page: 2437
  article-title: Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
  publication-title: J Clin Invest
– volume: 33
  start-page: 540
  issue: 6
  year: 2015
  end-page: 549
  article-title: Chemotherapy‐refractory diffuse large B‐cell lymphoma and indolent B‐cell malignancies can be effectively treated with autologous T cells expressing an anti‐CD19 chimeric antigen receptor
  publication-title: J Clin Oncol
– ident: e_1_2_6_5_1
  doi: 10.1016/j.celrep.2016.01.042
– ident: e_1_2_6_13_1
  doi: 10.1200/JCO.2014.56.2025
– ident: e_1_2_6_6_1
  doi: 10.1056/NEJMoa1411087
– ident: e_1_2_6_7_1
  doi: 10.1158/1078-0432.CCR-09-1339
– ident: e_1_2_6_3_1
  doi: 10.1016/j.ccr.2011.11.006
– ident: e_1_2_6_15_1
  doi: 10.1126/scitranslmed.aaf8621
– ident: e_1_2_6_8_1
  doi: 10.1200/JCO.2012.48.3685
– volume: 118
  start-page: 2427
  issue: 7
  year: 2008
  ident: e_1_2_6_4_1
  article-title: Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
  publication-title: J Clin Invest
– ident: e_1_2_6_9_1
  doi: 10.1016/S1470-2045(16)30167-X
– ident: e_1_2_6_16_1
  doi: 10.1182/blood.V128.22.4192.4192
– ident: e_1_2_6_11_1
  doi: 10.1200/JCO.2016.67.3467
– ident: e_1_2_6_10_1
  doi: 10.1200/JCO.2015.65.9789
– ident: e_1_2_6_14_1
  doi: 10.1182/blood.V128.22.998.998
– ident: e_1_2_6_2_1
  doi: 10.1172/JCI63186
– ident: e_1_2_6_12_1
  doi: 10.1182/blood-2014-05-552729
SSID ssj0009908
Score 2.1424935
SecondaryResourceType review_article
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 88
SubjectTerms Immunotherapy
Lymphoma
Title Immunotherapy in lymphoma
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhon.2408
https://www.ncbi.nlm.nih.gov/pubmed/28591421
https://www.proquest.com/docview/1906622417
https://www.proquest.com/docview/1907324333
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7IHsQX75fqlAqiT91ck6bNo6hjCpsgDgY-lKRNUJyduO1h_npP0suYFxCfWuhp0-TknPPlcr4AnHDZIimR0pOUU4-mmnk8QsNLFeE60BEViUlO7vZYp09vB8Gg2FVpcmFyfohqws1YhvXXxsCFHDfnpKFPqCXDz4Xut0WYoc2_up8zR6GTtU7YNwSyiBpK3tlzv1m-uBiJvsHLRbRqw017DR7LH813mbw0phPZSD6-cDj-rybrsFqgUPci7zYbsKSyTVjuFuvsW-DcmLSRIjlr5j5n7nCGah-9im3ot68fLjtecYiCl-DgE61Ac2x2RZRkkRYyFNIXaGkJwYEQ1UIFiUCr10EQMYLORichkVwTdGQh3iUB2YFaNsrUHrjS1ykTqVCI4SiOZDgXCD9IhNFPBkJxB87KBo2TgmHcHHQxjHNuZD_Gmsampg4cV5JvOavGDzL1UidxYVfjGOELYwZ1hPiJ6jFahFnmEJkaTa1MiDCREOLAbq7LqhBL10f9lgOnViO_lh537nrmuv9XwQNY8U3EtxM0dahN3qfqEPHKRB7ZnvkJh1bkKw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7MCeqL90t1agXRp26u6S34JOLYdJsgG_gglKRNUJyd6PYwf70n6WXMC4hPLfT0kpx8J1-Sni8Ax5TXSUw4t7hDHcuJpWfRAIEXC0KlKwOHRSo5udP1mn3n-t69L8F5nguT6kMUE24KGTpeK4CrCenaVDX0Ed2kBLrmYF4vzylGdDfVjsIwq8OwrSRkkTfkyrNndi2_c7Yv-kYwZ_mq7nAaK_CQf2r6n8lzdTzi1ejji4rjP8uyCssZETUv0pazBiWRrMNCJ1tq3wCjpTJHsvysifmUmIMJen74wjah37jqXTatbB8FK8LxJwJBUqx5QQT3Asm4z7jNEGwRwbGQI5lwI4bAl64beATjjYx8wqkkGMt8PItcsgXlZJiIHTC5LWOPxUwgjXNwMEMpQwZCAuwAucsENeA0r9EwykTG1V4XgzCVR7ZDLGmoSmrAUWH5mgpr_GBTyZ0SZtB6D5HBeJ4iHj4-oriMoFArHSwRw7G28ZEpEkIM2E6dWbxEK_Y5dt2AE-2SX98eNm-76rj7V8NDWGz2Ou2w3ere7MGSrQiAnq-pQHn0Nhb7SF9G_EA300_cEehJ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8NAEB60QvHF-4hWjSD6lNZmN8c-ilpatVXEQsGHsJvsoljTou1D_fXO5ir1APEpgUyy2Z2dmW-P-RbgiIk6iYgQlqCMWjRSrsV8NLxIEqYc5VMe6uTkdsdtdulVz-lluyp1LkzKD1FMuGnLSPy1NvBhpGpT0tAn1JLm55qHBepilNSA6H5KHYVeNvHCtmaQRdiQE8-e2rX8zdlQ9A1fzsLVJN40luEx_9N0m8lLdTwS1fDjC4nj_6qyAksZDDXP0n6zCnMyXoNyO1toXwejpfNGsuysifkcm_0J6n3wyjeg27h8OG9a2SkKVoijTzQDxbDdJZHC9RUXHhc2R1MLCY6EqOLSCTmavXIc3yXobVToEcEUQU_m4V3okE0oxYNYboMpbBW5POISQRzFoQxjHPEH8TH8CYdLZsBJ3qBBmFGM65Mu-kFKjmwHWNNA19SAw0JymNJq_CBTyXUSZIb1HiB-cV0NOzz8RPEYTUKvc_BYDsaJjIc4kRBiwFaqy6KQhK-P2nUDjhON_Fp60Lzt6OvOXwUPoHx30QhuWp3rXVi0dfRPJmsqUBq9jeUeYpeR2E866Sc2iub4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunotherapy+in+lymphoma&rft.jtitle=Hematological+oncology&rft.au=Ansell%2C+Stephen+M.&rft.au=Caligaris%E2%80%90Cappio%2C+Federico&rft.au=Maloney%2C+David+G.&rft.date=2017-06-01&rft.issn=0278-0232&rft.eissn=1099-1069&rft.volume=35&rft.spage=88&rft.epage=91&rft_id=info:doi/10.1002%2Fhon.2408&rft.externalDBID=10.1002%252Fhon.2408&rft.externalDocID=HON2408
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-0232&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-0232&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-0232&client=summon